Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05845034

A New Theory of Electrophysiological Mechanism of Atrial Fibrillation

A New Theory of Electrophysiological Mechanism of Atrial Fibrillation and Catheter Ablation Therapy for Atrial Fibrillation

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
The Second Affiliated Hospital of Kunming Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The electrophysiological mechanisms of atrial fibrillation remain disagreements. The goal of this clinical trail is to propose a new electrophysiological mechanism hypothesis of atrial fibrillation(AF),meanwhile, the investigators sought to test the hypothesis that the superposition electrograms (SPEs) recorded during atrial fibrillation could be used as target sites for catheter ablation of atrial fibrillation.

Detailed description

Catheter ablation for atrial fibrillation is a promising therapy, whose success is limited in part by uncertainty in the electrophysiological mechanisms of AF. The investigators recruited 100 subjects including paroxysmal(40%) and persistent (60%) AF. Cases were prospectively treated, in a 2-arm 1:1 design, by ablation SPEs followed by pulmonary vein isolation(PVI) ablation (n=50), or pulmonary vein isolation alone (n =50). All procedures are guided by CARTO (Biosense Webster) electroanatomic mapping system and ablation is performed using open irrigated catheters with contact force (CF) sensing (Thermocool SmartTouch, Biosense Webster). Study Group underwent electroanatomic mapping during AF. Using CARTO to identify areas associated with SPEs. Radiofrequency ablation of the area with SPEs was performed, aiming to eliminate SPEs and convert to sinus rhythm or atrial tachycardia.

Conditions

Interventions

TypeNameDescription
PROCEDUREPVI + SPEs ablationelectrophysiology substrate mapping is the critical difference between both groups.
PROCEDUREPVI ablationelectrophysiology substrate mapping is the critical difference between both groups.

Timeline

Start date
2023-04-01
Primary completion
2024-10-30
Completion
2025-03-30
First posted
2023-05-06
Last updated
2024-07-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05845034. Inclusion in this directory is not an endorsement.